Asthma News

BOSTON — Community engagement can help stock inhaler programs for underserved rural schools succeed, according to two posters presented at the American College of Allergy, Asthma & Immunology Annual Scientific Meeting.

During assessments of episodic memory, processing speed, and inhibition and attention, children with vs. without asthma had poorer scores, according to results published in JAMA Network Open.

BOSTON — Macrolides likely reduce severe exacerbations and improve quality of life and asthma control among patients with asthma, according to a presentation at the American College of Allergy, Asthma & Immunology Annual Scientific Meeting.

The fire that started at the Marck Industries Recycling Center in Rogers, Arkansas, on Oct. 16 prompted local officials to issue a hazardous smoke warning and advise residents with respiratory problems to shelter indoors.

BOSTON — Patients taking benralizumab experienced more asthma exacerbations than patients taking mepolizumab, according to an abstract presented at the CHEST Annual Meeting.

BOSTON — Combined treatments were associated with reduced asthma exacerbations compared with short-acting beta agonists alone, based on a review presented at the American College of Allergy, Asthma & Immunology Annual Scientific Meeting.

Following the discontinuation of Flovent in January, ICU admissions, inpatient admissions and ED visits related to asthma rose in comparison with previous years, according to study results from Epic Research.

BOSTON — Patients with mild asthma lowered their severe exacerbation risk by almost half by using as-needed albuterol-budesonide, according to data presented at the American College of Allergy, Asthma & Immunology Annual Scientific Meeting.

Patients with COPD, asthma and cystic fibrosis may soon be able to monitor their diseases by using/breathing through a tool that connects to their smartphone, according to a University of Pittsburgh press release.